FIELD: medicine.
SUBSTANCE: agents are used modulating stem cells proliferation when treating people and animals and accelerating recovery process after peripheral blood chemotherapy.
EFFECT: enhanced effectiveness of treatment.
79 cl, 28 dwg, 44 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITOR OF STEM CELL PROLIFERATION AND METHOD FOR ITS APPLICATION | 1995 |
|
RU2186579C2 |
| ARTIFICIAL ANTIGEN-PRESENTING CELLS AND METHODS FOR THEIR APPLICATION | 2018 |
|
RU2763798C1 |
| COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE ERYTHROCYTE COUNT | 2020 |
|
RU2814047C2 |
| RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND WAYS OF USE THEREOF | 2020 |
|
RU2816370C2 |
| CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF | 2014 |
|
RU2727447C2 |
| CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS | 2015 |
|
RU2724999C2 |
| INDUCED CASPASES AND METHODS FOR THEIR USE | 2017 |
|
RU2757058C2 |
| METHODS OF USING ZSCAN4 FOR HUMAN CELL REJUVENATION | 2014 |
|
RU2735141C2 |
| TREATMENT OF MALIGNANT NEOPLASM USING HUMANIZED CHIMERIC ANTIGEN RECEPTOR AGAINST BCMA | 2015 |
|
RU2751660C2 |
| AMATOXIN ANTIBODY-DRUG CONJUGATES AND USE THEREOF | 2020 |
|
RU2826004C2 |
